1 Cope, A. P., Schulze-Koops, H. & Aringer, M. The central role of T cells in rheumatoid arthritis. Clin Exp Rheumatol25, S4-11 (2007).
2 Cope, A. P. T cells in rheumatoid arthritis. Arthritis Res Ther10 Suppl 1, S1, doi:10.1186/ar2412 (2008).
3 Panayi, G. S., Lanchbury, J. S. & Kingsley, G. H. The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis and rheumatism35, 729-735, doi:10.1002/art.1780350702 (1992).
4 Van Boxel, J. A. & Paget, S. A. Predominantly T-cell infiltrate in rheumatoid synovial membranes. N Engl J Med293, 517-520, doi:10.1056/NEJM197509112931101 (1975).
5 Wang, W. et al. The Th17/Treg imbalance and cytokine environment in peripheral blood of patients with rheumatoid arthritis. Rheumatol Int32, 887-893, doi:10.1007/s00296-010-1710-0 (2012).
6 Zhang, S. The role of transforming growth factor beta in T helper 17 differentiation. Immunology155, 24-35, doi:10.1111/imm.12938 (2018).
7 Laurence, A. et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity26, 371-381, doi:10.1016/j.immuni.2007.02.009 (2007).
8 Yang, X. O. et al. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem282, 9358-9363, doi:10.1074/jbc.C600321200 (2007).
9 Yamamoto, T. et al. Expression of transforming growth factor-beta isoforms in human glomerular diseases. Kidney Int49, 461-469 (1996).
10 Gonzalo-Gil, E. & Galindo-Izquierdo, M. Role of transforming growth factor-beta (TGF) beta in the physiopathology of rheumatoid arthritis. Reumatol Clin10, 174-179, doi:10.1016/j.reuma.2014.01.009 (2014).
11 Itoh, Y., Saitoh, M. & Miyazawa, K. Smad3-STAT3 crosstalk in pathophysiological contexts. Acta Biochim Biophys Sin (Shanghai), 1-9, doi:10.1093/abbs/gmx118 (2017).
12 Robertson, S. A. et al. Seminal fluid drives expansion of the CD4+CD25+ T regulatory cell pool and induces tolerance to paternal alloantigens in mice. Biol Reprod80, 1036-1045, doi:10.1095/biolreprod.108.074658 (2009).
13 Chen, W. & Ten Dijke, P. Immunoregulation by members of the TGFbeta superfamily. Nature reviews. Immunology16, 723-740, doi:10.1038/nri.2016.112 (2016).
14 Yoshida, Y. et al. The transcription factor IRF8 activates integrin-mediated TGF-beta signaling and promotes neuroinflammation. Immunity40, 187-198, doi:10.1016/j.immuni.2013.11.022 (2014).
15 Marie, J. C., Liggitt, D. & Rudensky, A. Y. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor. Immunity25, 441-454, doi:10.1016/j.immuni.2006.07.012 (2006).
16 Li, M. O., Wan, Y. Y. & Flavell, R. A. T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity26, 579-591, doi:10.1016/j.immuni.2007.03.014 (2007).
17 Veldhoen, M., Hocking, R. J., Flavell, R. A. & Stockinger, B. Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nature immunology7, 1151-1156, doi:10.1038/ni1391 (2006).
18 Marijnissen, R. J. et al. Increased expression of interleukin-22 by synovial Th17 cells during late stages of murine experimental arthritis is controlled by interleukin-1 and enhances bone degradation. Arthritis and rheumatism63, 2939-2948, doi:10.1002/art.30469 (2011).
19 Lawlor, K. E., Campbell, I. K., O'Donnell, K., Wu, L. & Wicks, I. P. Molecular and cellular mediators of interleukin-1-dependent acute inflammatory arthritis. Arthritis and rheumatism44, 442-450, doi:10.1002/1529-0131(200102)44:2<442::AID-ANR63>3.0.CO;2-M (2001).
20 van den Broek, M. F., van den Berg, W. B., van de Putte, L. B. & Severijnen, A. J. Streptococcal cell wall-induced arthritis and flare-up reaction in mice induced by homologous or heterologous cell walls. Am J Pathol133, 139-149 (1988).
21 Hayer, S. et al. 'SMASH' recommendations for standardised microscopic arthritis scoring of histological sections from inflammatory arthritis animal models. Ann Rheum Dis, doi:10.1136/annrheumdis-2020-219247 (2021).
22 Kellner, H. Targeting interleukin-17 in patients with active rheumatoid arthritis: rationale and clinical potential. Ther Adv Musculoskelet Dis5, 141-152, doi:10.1177/1759720X13485328 (2013).
23 Chang, M. R., Lyda, B., Kamenecka, T. M. & Griffin, P. R. Pharmacologic repression of retinoic acid receptor-related orphan nuclear receptor gamma is therapeutic in the collagen-induced arthritis experimental model. Arthritis Rheumatol66, 579-588, doi:10.1002/art.38272 (2014).
24 Biggioggero, M., Crotti, C., Becciolini, A. & Favalli, E. G. Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection. Drug Des Devel Ther13, 57-70, doi:10.2147/DDDT.S150580 (2019).
25 Yamagata, T., Skepner, J. & Yang, J. Targeting Th17 Effector Cytokines for the Treatment of Autoimmune Diseases. Arch Immunol Ther Exp (Warsz)63, 405-414, doi:10.1007/s00005-015-0362-x (2015).
26 Allen, J. B. et al. Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta. J Exp Med171, 231-247, doi:10.1084/jem.171.1.231 (1990).
27 Fava, R. A. et al. Transforming growth factor beta 1 (TGF-beta 1) induced neutrophil recruitment to synovial tissues: implications for TGF-beta-driven synovial inflammation and hyperplasia. J Exp Med173, 1121-1132, doi:10.1084/jem.173.5.1121 (1991).
28 van Beuningen, H. M., van der Kraan, P. M., Arntz, O. J. & van den Berg, W. B. Transforming growth factor-beta 1 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint. Lab Invest71, 279-290 (1994).
29 Wahl, S. M., Allen, J. B., Costa, G. L., Wong, H. L. & Dasch, J. R. Reversal of acute and chronic synovial inflammation by anti-transforming growth factor beta. J Exp Med177, 225-230, doi:10.1084/jem.177.1.225 (1993).
30 Sakuma, M. et al. TGF-beta type I receptor kinase inhibitor down-regulates rheumatoid synoviocytes and prevents the arthritis induced by type II collagen antibody. Int Immunol19, 117-126, doi:10.1093/intimm/dxl128 (2007).
31 (!!! INVALID CITATION !!! 23).
32 Kuruvilla, A. P. et al. Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice. Proc Natl Acad Sci U S A88, 2918-2921, doi:10.1073/pnas.88.7.2918 (1991).
33 Santambrogio, L., Hochwald, G. M., Leu, C. H. & Thorbecke, G. J. Antagonistic effects of endogenous and exogenous TGF-beta and TNF on auto-immune diseases in mice. Immunopharmacol Immunotoxicol15, 461-478, doi:10.3109/08923979309035240 (1993).
34 Brandes, M. E., Allen, J. B., Ogawa, Y. & Wahl, S. M. Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals. J Clin Invest87, 1108-1113, doi:10.1172/JCI115073 (1991).
35 Song, X. Y., Gu, M., Jin, W. W., Klinman, D. M. & Wahl, S. M. Plasmid DNA encoding transforming growth factor-beta1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model. J Clin Invest101, 2615-2621, doi:10.1172/JCI2480 (1998).
36 Sancho, D. et al. CD69 downregulates autoimmune reactivity through active transforming growth factor-beta production in collagen-induced arthritis. J Clin Invest112, 872-882, doi:10.1172/JCI19112 (2003).
37 Thorbecke, G. J. et al. Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in mice. Proc Natl Acad Sci U S A89, 7375-7379, doi:10.1073/pnas.89.16.7375 (1992).
38 Marinova-Mutafchieva, L., Gabay, C., Funa, K. & Williams, R. O. Remission of collagen-induced arthritis is associated with high levels of transforming growth factor-beta expression in the joint. Clin Exp Immunol146, 287-293, doi:10.1111/j.1365-2249.2006.03204.x (2006).
39 Li, M. O., Wan, Y. Y., Sanjabi, S., Robertson, A. K. & Flavell, R. A. Transforming growth factor-beta regulation of immune responses. Annual review of immunology24, 99-146, doi:10.1146/annurev.immunol.24.021605.090737 (2006).
40 Li, M. O., Sanjabi, S. & Flavell, R. A. Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity25, 455-471, doi:10.1016/j.immuni.2006.07.011 (2006).
41 Kulkarni, A. B. et al. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A90, 770-774, doi:10.1073/pnas.90.2.770 (1993).
42 Letterio, J. J. et al. Autoimmunity associated with TGF-beta1-deficiency in mice is dependent on MHC class II antigen expression. J Clin Invest98, 2109-2119, doi:10.1172/JCI119017 (1996).
43 Gu, A. D., Wang, Y., Lin, L., Zhang, S. S. & Wan, Y. Y. Requirements of transcription factor Smad-dependent and -independent TGF-beta signaling to control discrete T-cell functions. Proc Natl Acad Sci U S A109, 905-910, doi:10.1073/pnas.1108352109 (2012).
44 Wiegertjes, R. et al. TGF-beta dampens IL-6 signaling in articular chondrocytes by decreasing IL-6 receptor expression. Osteoarthritis and cartilage27, 1197-1207, doi:10.1016/j.joca.2019.04.014 (2019).
45 Turner, M., Chantry, D. & Feldmann, M. Transforming growth factor beta induces the production of interleukin 6 by human peripheral blood mononuclear cells. Cytokine2, 211-216, doi:10.1016/1043-4666(90)90018-o (1990).
46 Walia, B., Wang, L., Merlin, D. & Sitaraman, S. V. TGF-beta down-regulates IL-6 signaling in intestinal epithelial cells: critical role of SMAD-2. FASEB journal : official publication of the Federation of American Societies for Experimental Biology17, 2130-2132, doi:10.1096/fj.02-1211fje (2003).
47 Khera, N. & Rajput, S. Therapeutic Potential of Small Molecule Inhibitors. J Cell Biochem118, 959-961, doi:10.1002/jcb.25782 (2017).
48 Zhong, S., Jeong, J. H., Chen, Z., Chen, Z. & Luo, J. L. Targeting Tumor Microenvironment by Small-Molecule Inhibitors. Transl Oncol13, 57-69, doi:10.1016/j.tranon.2019.10.001 (2020).
49 Sierra, J. R., Cepero, V. & Giordano, S. Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy. Mol Cancer9, 75, doi:10.1186/1476-4598-9-75 (2010).
50 Egan, P. J., van Nieuwenhuijze, A., Campbell, I. K. & Wicks, I. P. Promotion of the local differentiation of murine Th17 cells by synovial macrophages during acute inflammatory arthritis. Arthritis and rheumatism58, 3720-3729, doi:10.1002/art.24075 (2008).
51 Broeren, M. G. et al. Functional Tissue Analysis Reveals Successful Cryopreservation of Human Osteoarthritic Synovium. PLoS One11, e0167076, doi:10.1371/journal.pone.0167076 (2016).